XPhyto Therapeutics Corp.

Recent News

  • RETRANSMISSION: COVID-19 Test and Development Programs Update

    Vancouver, British Columbia--(Newsfile Corp. - March 23, 2020) - XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) (OTC PINK: XPHYF) ("XPhyto" or the "Company") is pleased to announce updates to its infectious disease programs, particularly as they relate to the COVID-19 (SARS-CoV-2) pandemic.XPhyto's wholly owned German subsidiary, Vektor Pharma TF...

    2020-03-23 3:02 AM ET
  • XPhyto Announces COVID-19 Test and Development Programs Update

    Vancouver, British Columbia--(Newsfile Corp. - March 20, 2020) - XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) (OTC Pink: XPHYF) ("XPhyto" or the "Company") is pleased to announce updates to its infectious disease programs, particularly as they relate to the COVID-19 (SARS-CoV-2) pandemic.XPhyto's wholly owned German subsidiary, Vektor Pharma TF...

    2020-03-20 4:15 PM ET
  • XPhyto Therapeutics Epilepsy Treatment Program

    Vancouver, British Columbia--(Newsfile Corp. - March 19, 2020) - XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) (OTC: XPHYF) ("XPhyto" or the "Company") is pleased to announce significant progress with respect to development of its cannabidiol ("CBD") based Epilepsy product. Further to the Company's press release dated December 9, 2019, titled...

    2020-03-19 12:45 PM ET
  • XPhyto Therapeutics Initiates Infectious Disease Programs

    Vancouver, British Columbia--(Newsfile Corp. - March 3, 2020) - XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) ("XPhyto" or the "Company") is pleased to announce that its wholly owned German subsidiary, Vektor Pharma TF GmbH ("Vektor"), will be commencing several research and development programs related to infectious disease. These programs include...

    2020-03-03 4:05 AM ET
  • Exclusive Strategic Partnership Commenced Between XPhyto Therapeutics and Elite Bavarian Brewing & Beverage Institute Weihenstephan

    Vancouver, British Columbia--(Newsfile Corp. - February 18, 2020) - XPhyto Therapeutics Corp. (CSE: XPHY) (FSE:4XT) ("XPhyto" or the "Company") is pleased to announce that its wholly owned German subsidiary, Bunker Pflanzenextrakte GmbH ("Bunker"), has begun its strategic exclusive partnership for research and development of cannabis focused products, specifically beverages, with...

    2020-02-18 4:05 AM ET
  • XPhyto Therapeutics Announces Strategic Supply, Import and Distribution Agreement for the German Cannabis Market

    Vancouver, British Columbia--(Newsfile Corp. - January 27, 2020) - XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) ("XPhyto" or the "Company") is pleased to announce that the Company has signed a three year definitive supply, import and distribution agreement (the "Agreement") with PharmaCielo Ltd. ("PharmaCielo"), one of the largest, highest quality,...

    2020-01-27 8:30 AM ET
  • Epilepsy Treatment to Be Developed with XPhyto Therapeutics' Oral Thin Film Delivery System

    Vancouver, British Columbia--(Newsfile Corp. - December 9, 2019) - XPhyto Therapeutics Corp.

    2019-12-09 4:05 AM ET
  • XPhyto Therapeutics Developing Epilepsy Treatment with Oral Thin Film Delivery System

    Vancouver, British Columbia--(Newsfile Corp. - December 6, 2019) - XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) ("XPhyto" or the "Company") is pleased to announce that the development of Epilepsy treatment products using its proprietary oral thin film delivery system will be a priority initiative for 2020. The Company is focusing...

    2019-12-06 5:05 PM ET